News & Updates
Filter by Specialty:

Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB
In the treatment of patients with rifampicin-resistant tuberculosis (TB), two bedaquiline-containing regimens, namely a 9-month all-oral regimen and a shorter 6-month regimen with 8 weeks of aminoglycoside, maintains superior efficacy to a 9-month injectable regimen through 132 weeks, according to long-term data from the STREAM 2 trial.
Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB
16 Oct 2024
Nationwide exercise programs a cost-effective way to improve public health in SG
Nationwide exercise programs can significantly reduce healthcare costs in Singapore by preventing diabetes, hypertension, and associated mortality, as suggested in a cost-utility analysis.
Nationwide exercise programs a cost-effective way to improve public health in SG
16 Oct 2024
Metastatic prostate cancer risk low in older men nearing age limit for PSA screening
Older men who have had prostate-specific antigen (PSA) testing and are approaching the age limit for recommended screening appear to have a relatively low risk of developing metastatic or fatal prostate cancer, suggests a recent study.
Metastatic prostate cancer risk low in older men nearing age limit for PSA screening
16 Oct 2024
Depression, anxiety tied to intragastric balloon intolerance, early removal
Intragastric balloons (IGBs) are a less-invasive alternative to metabolic bariatric surgery (MBS) in the treatment of obesity and its complications, but many Asians suffer intolerance and have a higher rate of early balloon removal relative to Caucasians, reports a Singapore study. Moreover, both depression and anxiety are associated with early IGB removal.
Depression, anxiety tied to intragastric balloon intolerance, early removal
16 Oct 2024
Long-term glucocorticoid exposure ups risk of incident CVD
Long-term glucocorticoid levels, particularly cortisone measured in scalp hair, are associated with a higher risk of incident cardiovascular disease (CVD) among younger adults, suggests a study.